FERG.UK

12,660

+0.96%↑

FERG.UK

12,660

+0.96%↑

FERG.UK

12,660

+0.96%↑

FERG.UK

12,660

+0.96%↑

FERG.UK

12,660

+0.96%↑

Search

ConvaTec Group PLC

Open

BrancheFinanzen

255.2 -0.7

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

254.2

Max

259.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

79M

Verkäufe

1.1B

KGV

Branchendurchschnitt

36.2

20.525

EPS

0.07

Dividendenrendite

2

Gewinnspanne

7.059

Angestellte

10,489

EBITDA

251M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+23.49% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.00%

4.36%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

126M

5.2B

Vorheriger Eröffnungskurs

255.9

Vorheriger Schlusskurs

255.2

ConvaTec Group PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Peer-Vergleich

Kursveränderung

ConvaTec Group PLC Prognose

Kursziel

By TipRanks

23.49% Vorteil

12-Monats-Prognose

Durchschnitt 318.86 GBX  23.49%

Hoch 375 GBX

Tief 305 GBX

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ConvaTec Group PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

7

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.